Introduction
The Notch1 gene belongs to the Notch/lin12 gene family which encodes large transmembrane proteins believed to function as receptors transmitting signals for cell fate determination in several species (for a review, see Artavanis-Tsakonas et al., 1995) . The extracellular portion of the Notch1 protein contains several EGF repeats and is thought to mediate receptor-ligand interaction (Fehon et al., 1990; Lindsell et al., 1995) while its intracellular domain, which includes six copies of a cdc10/SW16/ankyrin motif, is responsible for the transmission of the signal to the nucleus (Jarriault et al., 1995; Fortini and Artavanis-Tsakonas, 1994; Hsieh et al., 1996; Lu and Lux, 1996; Kopan et al., 1996) . The human homolog of Notch1, TAN-1, has been identi®ed as a locus involved in the t(7;9)(q34;q34.3) chromosome translocation and was found to be deleted of sequences encoding the extracellular domain by this translocation event (Ellisen et al., 1991) . Other activated forms of mammalian Notch1, deleted of the extracellular domain, have been shown to in¯uence the choice between the CD4 and CD8 T cell lineages , as well as that between ab versus gd T cell lineages (Washburn et al., 1997) , to inhibit differentiation of dierent cell types in vitro (Milner et al., 1996; Nye et al., 1994; Kopan et al., 1994) and to induce neoplastic transformation of bone marrow cells transplanted in vivo (Pear et al., 1996) .
We previously reported that the Notch1 gene was rearranged in more than 50% of T-cell lymphomas induced by Moloney MuLV infection of MMTV D /myc transgenic (Tg) mice (Girard et al., 1996) . In these tumors, the proviruses were inserted upstream of exons coding for the transmembrane domain of Notch1 and were found in both transcriptional orientations. They appeared to activate the Notch1 gene by a promoter or enhancer insertion mechanism leading to high expression of truncated Notch1 transcripts deleted of most of the sequences coding for the extracellular domain. Several species of truncated Notch1 proteins were also detected in all Notch1-rearranged tumors: they appeared to originate from the translation of the truncated RNAs as well as from the processing of fulllength Notch1 precursors. Therefore, the expression of truncated Notch1 proteins appears to play a major role in the transformation induced by proviral activation of Notch1.
Interestingly, in several tumors with a Notch1 rearrangement, overexpression of full-length Notch1 RNA (8/10 kb) and/or proteins (280/330 kD) could also be detected (Girard et al., 1996) , suggesting that this event could also participate in the transformation process. We have now tested this hypothesis directly using a genetic approach. We used mutant mice generated by homologous recombination and which harbor a deletion of the Notch1 gene (Notch1
) in the same region previously found to be the site of provirus integrations detected with probe D (Girard et al., 1996; Conlon et al., 1995) . In these heterozygote Notch1 +/7 mice, any provirus insertion detected with probe D will necessarily occur on the normal Notch1 allele. Some tumors will therefore harbor mutations in both Notch1 alleles and will be unable to code for wild-type full- ) background, indicating that the full-length Notch1 allele is dispensable in tumors harboring an activated Notch1 gene. mice) disseminated to the spleen, lymph nodes and sometimes in other organs (kidneys or the liver), in accordance to what was previously described (Girard et al., 1996) (Girard et al., 1996) : one, detected with probe D on EcoRV digests, was mapped upstream of exon sequences encoding the transmembrane domain of Notch1 (Figure 1 ) and another, detected with probe K on KpnI digests, was located further downstream of the ®rst site. Rearrangements detected with probe D are known to disrupt the Notch1 gene and to activate transcription of downstream Notch1 sequences and at the same time to interrupt transcription of full-length transcripts at the site of provirus integration (Girard et al., 1996) . We used the same probes to screen for rearrangements in the new set of tumors. With probe D, 9 out of 21 (43%) thymomas from the Tg +/7 / Notch1 +/+ mice were found to harbor a rearrangement disrupting the Notch1 gene, while a total of 16 out of these 21 thymomas (76%) showed rearrangement with both probes D and K (including one detected with the probe M) ( Table 1) . Probe D detected Notch1 rearrangements in 15 out of 26 (58%) thymomas from the Tg +/7 /Notch1 +/7 mice, and a total of 19 out of 26 thymomas (73%) were found to have rearrangements with both probes. From these data, it is clear that the absence of one copy of the Notch1 alleles does not signi®cantly aect the frequency at which Notch1 is targeted by provirus insertion. Since both Notch1 alleles are disrupted in the Tg
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+/7 tumors harboring a provirus inserted in Notch1 (and detectable with probe D) and that no full-length Notch1 transcripts or proteins can be produced, these results indicate that the full-length Notch1 allele is dispensable for the development of this subset of T-cell lymphomas in MMTV D /myc Tg mice. 
Provirus insertion in
Notch1
+/7 mice was performed on in®ltrated lymph nodes exhibiting a monoclonal pattern of Notch1 rearrangement detectable with probe D. Individual tumor pieces from enlarged lymph nodes were split in three parts for analysis of DNA, RNA and proteins to further ensure that these analyses were done on the same tumor population. One unrearranged and one rearranged tumor with a wild-type Notch1 +/+ genotype were analysed, together with one unrearranged and ®ve rearranged tumors with a Notch1 16/21 (76%) 19/26 (73%) a All rearrangements were tumor-speci®c and were detected by digesting tumor DNAs with the speci®ed restriction endonucleases and hybridizing with the indicated Notch1 probes. As previously reported (Girard et al., 1996) , several of the rearranged fragments were underrepresented, indicating that these tumors consisted of more than one tumor cell population Full-length Notch1 in mouse T cell lymphoma L Girard and P Jolicoeur cells in®ltrating the tumors or from another population of tumor cells exhibiting no provirus insertion in Notch1. However, the wild-type allele which had sustained insertion of the provirus was easily detected as a fragment of distinct length in each tumor ( Figure  2 , lanes 6 ± 10).
To con®rm that the rearrangements detected within the Notch1 gene re¯ected the presence of MuLV proviruses, to map the sites of integration precisely, and to determine the transcriptional orientation of the proviruses in these tumors, a restriction analysis was performed, as previously described (Girard et al., 1996) . The location and orientation of the proviruses were further con®rmed by PCR ampli®cation of provirus-cell junctions, as previously performed with tumors from Tg +/7 /Notch1 +/+ mice (Girard et al., 1996) . The provirus insertion sites are shown in Figure  1 . They were mapped in the same region that was previously found as the main cluster of provirus integration in Tg +/7 /Notch1 +/+ mice (Girard et al., 1996) . Therefore, our results show that the tumors arising in Tg +/7 /Notch1 +/7 mice and containing a provirus inserted in Notch1 harbor no wild-type Notch1 allele since one allele has been mutated by deletion during homologous recombination, while the other allele has sustained insertion of a provirus (Notch1 +/+ mice (Girard et al., 1996) . The analysis with the extracellular probe A (Figure 3b ) and probe D (data not shown) gave almost identical results: As expected, no or very little full-length Notch1 transcripts (8/10 kb) were detected in most of these tumors which harbor mutations in both Notch1 alleles. One tumor Full-length Notch1 in mouse T cell lymphoma L Girard and P Jolicoeur (LN30902) exhibited higher expression of full-length Notch1 RNAs in addition to truncated transcripts (Figure 3b, lane 9) , suggesting that this expression might originate from a second tumor subpopulation or from normal surrounding tissue. Consistent with this interpretation, the 7.2 kbp germline EcoRV fragment in this tumor can be detected at a level of 6% relative to the rearranged fragment (Figure 2, lane 9) .
Western analysis was performed on the same tumors with the Ab-intra-1, Ab-extra-1 and Ab-extra-2 antibodies. The analysis with the Ab-intra-1 antibody revealed higher expression of truncated Notch1 proteins (86 ± 110 kD) in most Notch1-rearranged Tg +/7 /Notch1 +/7 tumors as compared to non-rearranged tumors (Figure 4a , lanes 6 ± 10). This pattern is similar to what we reported previously for Tg +/7 / Notch1 +/+ tumors (Girard et al., 1996) . With the Abextra-1 (Figure 4b ) and Ab-extra-2 (data not shown) antibodies, the expression level of Notch1 full-length protein was found to be comparable to that of the unrearranged controls for three out of ®ve tumors (Figure 4b, lanes 6, 8, 10 ). This low level of full-length Notch1 protein expression was expected since these tumors harbor no normal Notch1 allele. However, two tumors (LN28847 and LN30902) (Figure 4b , lanes 7 and 9 respectively) unexpectedly showed higher levels of full-length Notch1 proteins (280 kD). In tumor LN30902, the slightly elevated level of this full-length Notch1 protein (Figure 4b, lane 9) is consistent with the higher expression of the full-length RNA species (Figure 3b, lane 9) , and is likely to originate from normal (non-tumor) in®ltrated tissues or from other tumor cells without Notch1 rearrangement. In contrast, tumor LN28847 exhibited very high levels of the 280 kD protein together with a slightly increased expression of the 330 kD species (Figure 4b, lane 7) , even though this tumor showed very little full-length RNA expression (Figure 3b, lane 7) . This overexpressed 280 kD protein could be encoded by the very highly expressed 6.5 kb RNA species detected in this tumor and which encode sequences hybridizing with probes A, D and K. Alternatively it could be encoded by the low levels of one of the aberrant, high molecular weight RNA species and be stabilized posttranslationally in this tumor.
Discussion
We previously reported that the Notch1 gene was very frequently (52%) truncated and activated by the insertion of a provirus in T-cell lymphoma arising in MMTV D /myc Tg mice infected with Moloney MuLV (Girard et al., 1996) . Since the normal unmutated Notch1 allele was also frequently overexpressed in the +/+ or Notch1 +/7 genotype. Protein extracts (125 mg) were separated on 4 ± 8% SDS-polyacrylamide gels and analysed with the primary rabbit antibody Ab-intra-1 (a) or Abextra-1 (b). Tumors are the same as those shown in Figure 3 Full-length Notch1 in mouse T cell lymphoma L Girard and P Jolicoeur tumors in which the other Notch1 allele was provirally activated, we have tested whether its presence was required for tumorigenesis. The genetic approach used here to answer this question indicated that the frequency of Notch1 rearrangements in T-cell tumors from Moloney MuLV-inoculated MMTV D /myc Tg mice bred on a Notch1 +/+ or a Notch1 +/7 background was similar and was not in¯uenced by the absence of one Notch1 allele. Moreover, we could document that in several Notch1 +/7 tumors, Notch1 rearrangement (detected with probe D) occurred on the remaining normal allele, thus indicating that in these tumors, both Notch1 alleles harbor a distinct mutation. Therefore, full-length Notch1 transcripts are not expected to be produced in these tumor cells unless one postulates that the proviruses inserted within Notch1 introns are spliced out from the ®nal Notch1 transcripts. This possibility is rather unlikely in view of the fact that the LTR of the proviruses integrated in the same orientation as the target gene would normally provide a transcription termination signal (in the U3 LTR region) and that for either proviral orientation, Notch1 transcription would have to pass through an active LTR or cryptic promoter that drives expression of truncated transcripts. Since no full-length Notch1 RNA is likely to be expressed in Notch1 +/7 tumor cells which had sustained a provirus integration in Notch1, this implies that the full-length Notch1 allele does not play a signi®cant role in the development of tumors already harboring an activated truncated Notch1 allele. Notch1 expression analysis performed on tumors which appeared most monoclonal indeed revealed the absence or low levels of full-length RNA in all analysed tumors except one (LN30902). In this tumor, normal in®ltrating cells or minor tumor cell subpopulations may have contributed to the expression of these fulllength Notch1 RNA species. More puzzling is the very high expression of an aberrant 6.5 kb truncated RNA detectable with the extracellular (probe A or probe D) as well as with the intracellular (probe K) probes in tumor 28847. Since this aberrant transcript hybridized with probe D, it must be encoded by the normal Notch1 allele which has sustained the provirus insertion. The structure of this transcript has not been investigated further, but appears to be distinct from the other truncated Notch1 RNAs described earlier, which either hybridized with the extracellular or intracellular probes, but not with both (Girard et al., 1996) . It is possible that the high levels of the Notch1 proteins detected in this tumor at an apparent molecular weight of 280 kD (Figure 4b , lane 7) are encoded by this 6.5 kb RNA. Alternatively, although possibly less likely, this 280 kD protein could be encoded by another aberrant RNA species expressed at low levels and be stabilized post-translationally in this tumor to reach high levels. The absence of similarly overexpressed 280 kD protein in other tumors indicate that their overexpression is not required for the oncogenic process.
The high expression levels of full-length Notch1 RNA in several Notch1 +/+ tumors harboring activated truncated Notch1 RNAs suggested a transactivation eect (Girard et al., 1996) . In C. Elegans, the activity of the Notch1 homologue, lin-12, has been shown, by using a lin-12 promoter/lacZ reporter construct, to positively autoregulate lin-12 transcription (Wilkinson et al., 1994) . This feedback loop appears to regulate the process of cell speci®cation of the hermaphrodite gonad. In this process two neighboring cells, one destined to become an anchor cell (AC), the other to become a ventral uterine precursor cell (VU) express varying levels of lin-12 and of its putative ligand lag-2. These are regulated in a reciprocal manner, in which the cell expressing a higher level of lin-12 develop into the VU cell whereas that expressing a higher level of lag-2 is destined to become the AC cell (Kenyon, 1995) . Therefore, lin-12 appears to upregulate itself through a cis-acting 5' regulatory sequence in the lin-12 gene and this is apparently necessary for the speci®cation of the VU fate (Christensen et al., 1996; Wilkinson et al., 1994) . In Drosophila however, a similar transactivation eect was not observed when various activated Notch constructs deleted of most or all of the extracellular domain were ectopically expressed (Rebay et al., 1993) . In the other biological systems (mammalian cells in culture and Xenopus embryos), in which Notch homologues have been studied, a transactivation eect has not been reported either. It has only been detected by RNase protection analysis in two primary T-cell leukemia with TAN-1 translocation (Ellisen et al., 1991) . However, the technique used and the length of the fragment protected (394 bp) prevented a full description and appreciation of this phenomenon. Interestingly, overexpression of full-length TAN-1 proteins has also been detected more recently in murine T-cell lymphomas induced by in vivo transplantation of bone marrow cells infected with retroviral vectors carrying activated truncated forms of TAN-1 cDNA (Pear et al., 1996; Aster et al., 1994) . Our study strongly suggests that the high levels of the full-length transcripts and proteins observed in various systems in which an activated Notch1 transcript is expressed are not essential for tumor induction and do not participate in the selective advantage conferred by the activated Notch1. Rather, when overexpressed in the Notch1 +/+ tumors, full-length Notch1 appears to play no apparent role and the increase in the level of the truncated Notch 1 proteins due to processing of the full-length precursor (Girard et al., 1996) is not required for the oncogenic process and may be a vestigial component of a signaling pathway. We cannot rule out however that the full-length Notch1 proteins still play some biological role in these tumors which has escaped our assay system. In addition, this apparent transactivation eect may still be required in higher organisms for the fate determination of some normal cell lineages.
Materials and methods
Mice and viruses
The MMTV D /myc transgenic mice were bred on CD1 background and have previously been described (Paquette et al., 1992) . The Notch1 +/7 mice were also bred on CD1 background and were kindly provided by J. Rossant (Conlon et al., 1995) . Genotyping for the Notch1 allele was done by Southern blot hybridization on KpnI digests using the probe K, scoring for the presence (targeted allele) or absence (normal allele) of a 7.5 kbp band (Figure 1) , as described by Conlon et al. (1995) . Newborn mice (548 h) were inoculated with Moloney MuLV (10 5 Pfu/ml) intraperitoneally.
DNA analysis
DNA extraction, digestion with restriction endonucleases, separation of DNA fragments by agarose gel electrophoresis and hybridization with 32 P-labeled probes by the method of Southern were performed as previously described (Girard et al., 1996) .
PCR
Tumor DNA (1 mg) was ampli®ed by PCR using the Notch1-speci®c primers 233 or 234 and the Moloney LTRspeci®c primers 110 or 112 as described (Girard et al., 1996) . The PCR products were con®rmed by hybridization with Notch1 probes.
RNA analysis
RNA was isolated, separated on 1% formaldehyde-agarose gels, transferred by the Northern blot procedure to Hybond-N membranes (Amersham Co) and hybridized as described (Girard et al., 1996) .
Probes
The Notch1 probes A, M, D and K were described previously (Girard et al., 1996) . All probes were labeled with [
32 P]dATP and [ 32 P]dCTP by the random primer method, as described (Hanna et al., 1993) .
Western analysis and antibodies
Protein extractions and Western immunoblotting were done as described (Girard et al., 1996) . The antibodies Ab-Intra-1, Ab-Extra-1 and Ab-Extra-2 were described previously (Girard et al., 1996) and used at dilutions of 1 : 1500 or 1 : 2000 for Western blots.
